Anthem Biosciences Ltd (ANTHEM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 10039665, "name": "Anthem Bioscienc", "stock_name": "Anthem Bioscienc", "full_name": "Anthem Biosciences Ltd", "name_url": "stocks-analysis/anthem-bioscienc", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "840.80", "chg": 15.35, "chgp": "1.86%", "dir": 1, "prev_price": "825.45", "mcapval": "46,713.00 Cr", "mcap": "Mid Cap", "scripcode": 544449, "symbol": "ANTHEM", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE0CZ201020", "curr_date": "Aug 07, 03:30 PM", "curr_time": "14:10 PM", "last_traded_at": "Aug 07, 03:30 PM IST", "bse_nse_vol": "4.99 lacs", "exc_status": "Active", "traded_date": "Aug 07, 2026", "traded_date_str": "2026 08 07", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/anthem-bioscienc-10039665-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Anthem Biosciences Ltd is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/anthem-biosciences-ltd-is-rated-hold-by-marketsmojo-4141754", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AnthemBioscienc_mojoScore_4141754.png", "date": "2026-08-07 10:10:03", "description": "Anthem Biosciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 21 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 August 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Anthem Biosciences Ltd Technical Momentum Shifts Amid Mixed Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-ltd-technical-momentum-shifts-amid-mixed-signals-4137217", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AnthemBioscienc_technicaldot_4137217.png", "date": "2026-08-05 08:08:05", "description": "Anthem Biosciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a modest day decline of 1.43%, the stock’s technical indicators reveal a complex interplay of signals that investors should carefully analyse amid evolving market conditions." }, { "title": "Anthem Biosciences Ltd Technical Momentum Shifts to Bullish Amid Strong Price Gains", "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-ltd-technical-momentum-shifts-to-bullish-amid-strong-price-gains-4135585", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AnthemBioscienc_technicaldot_4135585.png", "date": "2026-08-04 08:11:41", "description": "Anthem Biosciences Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators that suggest strengthening investor confidence. The stock’s recent performance, coupled with upgrades in key technical parameters, signals a positive outlook for this mid-cap pharmaceutical and biotechnology player." }, { "title": "Anthem Biosciences Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/anthem-biosciences-ltd-is-rated-hold-4122512", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AnthemBioscienc_mojoScore_4122512.png", "date": "2026-07-27 10:10:04", "description": "Anthem Biosciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 21 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 July 2026, providing investors with the most up-to-date view of the company’s performance and outlook." }, { "title": "Anthem Biosciences Ltd Dips 0.80%: 4 Key Events Shaping This Week’s Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-ltd-dips-080-4-key-events-shaping-this-weeks-volatility-4120011", "imagepath": "", "date": "2026-07-25 09:02:42", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>20 Jul:</strong> Strong technical momentum lifts stock 1.99% to Rs.791.55</p>\n <p><strong>21 Jul:</strong> Technical indicators signal bullish outlook; stock steady at Rs.791.70</p>\n <p><strong>22 Jul:</strong> Sharp gap down and Q1 FY27 results trigger 5.58% drop to Rs.778.35</p>\n <p><strong>23 Jul:</strong> Mixed technical signals; stock marginally up at Rs.779.30</p>\n <p><strong>24 Jul:</strong> Week closes lower at Rs.769.90, down 1.21% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div cl..." }, { "title": "Anthem Biosciences Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4117152", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AnthemBioscienc_technicaldot_4117152.png", "date": "2026-07-23 08:05:33", "description": "Anthem Biosciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent day decline of 1.69%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators, prompting a reassessment of its near-term trend and investor outlook." }, { "title": "Anthem Biosciences Q1 FY27: Sharp Profit Decline Amid Revenue Contraction Raises Growth Concerns", "link": "https://www.marketsmojo.com/news/result-analysis/anthem-biosciences-q1-fy27-sharp-profit-decline-amid-revenue-contraction-raises-growth-concerns-4115322", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AnthemBioscienc_quaterlyResult_4115322.png", "date": "2026-07-22 09:48:50", "description": "Anthem Biosciences Limited, a mid-cap pharmaceutical and biotechnology company with a market capitalisation of ₹43,197 crores, reported a concerning set of results for Q1 FY27, with net profit declining 36.79% quarter-on-quarter to ₹119.94 crores from ₹189.76 crores in Q4 FY26. The company's stock traded at ₹767.00 on July 22, 2026, down 3.12% from the previous close, reflecting investor disappointment with the quarterly performance." }, { "title": "Anthem Biosciences Ltd Opens 5.26% Lower in Sharp Gap Down as Technicals Point to Further Weakness", "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-ltd-opens-with-weak-start-significant-gap-down-amid-market-concerns-4114799", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AnthemBioscienc_gapdown_4114799.png", "date": "2026-07-22 09:40:52", "description": "" }, { "title": "Anthem Biosciences Ltd Technical Momentum Shifts Signal Bullish Outlook", "link": "https://www.marketsmojo.com/news/stocks-in-action/anthem-biosciences-ltd-technical-momentum-shifts-signal-bullish-outlook-4111830", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AnthemBioscienc_technicaldot_4111830.png", "date": "2026-07-21 08:08:21", "description": "Anthem Biosciences Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by robust price action, positive signals from key technical indicators such as MACD and moving averages, and a significant outperformance relative to the broader market indices." } ], "total": 66, "sid": "10039665", "stock_news_url": "https://www.marketsmojo.com/news/anthem-biosciences-10039665" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript", "datetime": "27-Jul-2026", "details": "Transcript of Earnings Conference Call held on July 22 2026.", "source": "BSE" }, { "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report", "datetime": "24-Jul-2026", "details": "Anthem Biosciences Limited has submitted the Exchange the voting results and a copy of scrutinizer report of the 20th Annual General Meeting of the Company held on July 22 2026", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome", "datetime": "22-Jul-2026", "details": "Audio recording of Earnings Call for the quarter ended June 30 2026.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Anthem Biosciences Ltd has declared <strong>100%</strong> dividend, ex-date: 25 Jun 26", "dt": "2026-06-25", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

20 Jul: Strong technical momentum lifts stock 1.99% to Rs.791.55

21 Jul: Technical indicators signal bullish outlook; stock steady at Rs.791.70

22 Jul: Sharp gap down and Q1 FY27 results trigger 5.58% drop to Rs.778.35

23 Jul: Mixed technical signals; stock marginally up at Rs.779.30

24 Jul: Week closes lower at Rs.769.90, down 1.21% on the day

Week Open

Read full news article

Anthem Biosciences Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-07-23 08:05:33

Anthem Biosciences Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent day decline of 1.69%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators, prompting a reassessment of its near-term trend and investor outlook.

Read full news article

Anthem Biosciences Q1 FY27: Sharp Profit Decline Amid Revenue Contraction Raises Growth Concerns

2026-07-22 09:48:50

Anthem Biosciences Limited, a mid-cap pharmaceutical and biotechnology company with a market capitalisation of ₹43,197 crores, reported a concerning set of results for Q1 FY27, with net profit declining 36.79% quarter-on-quarter to ₹119.94 crores from ₹189.76 crores in Q4 FY26. The company's stock traded at ₹767.00 on July 22, 2026, down 3.12% from the previous close, reflecting investor disappointment with the quarterly performance.

Read full news article

Anthem Biosciences Ltd Opens 5.26% Lower in Sharp Gap Down as Technicals Point to Further Weakness

2026-07-22 09:40:52

Read full news article

Anthem Biosciences Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-07-21 08:08:21

Anthem Biosciences Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underscored by robust price action, positive signals from key technical indicators such as MACD and moving averages, and a significant outperformance relative to the broader market indices.

Read full news article